Theravance Biopharma, Inc. (TBPH) Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Fusion Pharmaceuticals Inc. (FUSN) Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses […]
Read MoreCatalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. CPRX $15.2300 0.3600 % 2.4200 Catalyst Pharm Inc Sector : Medical Industry : Medical – Drugs Signal Short Term Trend Long Term Trend BUY UP UP Day: 2.42% […]
Read MoreAltimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company’s lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatitis. ALT $21.0900 -0.9900 % -4.4800 Altimmune Inc […]
Read MoreBioVie Inc. (BIVI) BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis. Infinity Pharmaceuticals, Inc. (INFI) Infinity Pharmaceuticals, Inc., a biopharmaceutical […]
Read MoreCatalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. CPRX $13.9500 0.1100 % 0.7900 Catalyst Pharm Inc Sector : Medical Industry : Medical – Drugs Signal Short Term Trend Long Term Trend BUY UP UP Day: 0.79% […]
Read MoreBuy Price: $7.35 or better Sell Price: TradersPro Sell Signal Rain Therapeutics Inc., a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States. Its lead product candidate is milademetan, a small molecule oral inhibitor of mouse double minute 2, which is oncogenic in various cancers. The stocks founds […]
Read MoreCTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. CTIC $6.5700 0.2500 % 3.9600 Cti Biopharm Corp Sector : Medical Industry : Medical – Drugs Signal Short Term Trend Long Term Trend BUY UP UP Day: 3.96% Wk: -6.28% Mo: […]
Read MoreBeyond Air, Inc. (XAIR) Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. Dynavax Technologies Corporation (DVAX) Dynavax Technologies Corporation, a biopharmaceutical […]
Read MoreChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis. CCXI $25.6500 -1.1100 % -4.1500 Chemocentryx Inc […]
Read MoreChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. CCXI $26.7600 1.9800 % 7.9900 Chemocentryx Inc Sector : Medical Industry : Medical – Drugs Signal Short Term Trend Long Term Trend BUY UP UP Day: 7.99% Wk: 2.33% Mo: […]
Read MoreAltimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company’s lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatitis. ALT $11.2000 -0.5000 % -4.2700 Altimmune Inc […]
Read MoreBridgeBio Pharma, Inc. (BBIO) BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Supernus Pharmaceuticals, Inc. (SUPN) Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and […]
Read MoreProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. PRPH $10.3800 0.4700 0 Prophase Labs Inc Sector : Medical Industry : Medical – Drugs Signal […]
Read MoreCTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. CTIC $5.9500 -0.1300 % -2.1400 Cti […]
Read MoreSanderson Farms, Inc. (SAFM) Sanderson Farms, Inc., an integrated poultry processing company, produces, processes, markets, and distributes fresh, frozen, and prepared chicken products in the United States. The company sells ice-packed, chill-packed, bulk-packed, and frozen chicken primarily under the Sanderson Farms brand name to retailers. RCM Technologies, Inc. (RCMT) RCM Technologies, Inc. provides business and […]
Read More